Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
P 2 (3)
P 3 (1)

Trial Status

Completed6
Recruiting5
Unknown3
Active Not Recruiting1
Not Yet Recruiting1
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06899191Not ApplicableCompleted

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

NCT07463209Not ApplicableNot Yet RecruitingPrimary

Integrating New Skills Into Diabetes Education With CGM

NCT04783441Not ApplicableRecruiting

Use of CGM in Kidney Transplant Recipients

NCT07251257RecruitingPrimary

The Seafarers' Continuous Glucose Monitoring Systems Study

NCT04225455Active Not RecruitingPrimary

The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes

NCT06167499Not ApplicableTerminated

Therapeutic Education Consultations With Diabetic Patients Treated With Intensified Insulin Therapy

NCT05663931Not ApplicableRecruiting

Diabetes Toolkit at Discharge

NCT06654713Recruiting

Commercial or Open Source Closed Loop Impact on Pregnancy Study

NCT06959316Recruiting

T1D Pregnancy & Me

NCT03703440Not ApplicableCompleted

Group Education Trial to Improve Transition in Type 1 Diabetes

NCT05915338CompletedPrimary

Training on Using ıInsulin in Patients With Type 2 Diabetes

NCT03345004Phase 2Completed

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

NCT03283566Phase 2Completed

Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT

NCT03682640Phase 2Unknown

Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

NCT01932944Completed

Accuracy Characterization Study

NCT01559025Phase 3Unknown

Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus

NCT01745900UnknownPrimary

Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

Showing all 17 trials

Research Network

Activity Timeline